Mhairi K Doris1, Marc R Dweck, Zahi A Fayad. 1. aCentre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK bTranslational and Molecular Imaging Institute cZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Abstract
PURPOSE OF REVIEW: As our understanding of cardiovascular disease has advanced over the past decades, multiple novel treatment strategies have been developed with the hope of reducing the global morbidity and mortality associated with this condition. Large-scale trials to test such novel therapies using clinical end points are expensive, leading to interest in phase II clinical trials with imaging-derived outcome measures. RECENT FINDINGS: Noninvasive imaging techniques that assess changes in both atherosclerotic disease burden and plaque composition in response to therapy are well established. With the advent of molecular techniques and hybrid imaging, we now have the ability to assess disease activity alongside these standard anatomic assessments. This multifaceted approach has the potential to provide a more comprehensive assessment of the actions and efficacy of novel therapies in the carotids, aorta and coronary arteries. SUMMARY: This review will examine how advanced noninvasive imaging strategies have been used to investigate drug efficacy in intervention trials to date, and crucially how these approaches are set to evolve and play a central role in developing the next generation of atherosclerotic medication.
PURPOSE OF REVIEW: As our understanding of cardiovascular disease has advanced over the past decades, multiple novel treatment strategies have been developed with the hope of reducing the global morbidity and mortality associated with this condition. Large-scale trials to test such novel therapies using clinical end points are expensive, leading to interest in phase II clinical trials with imaging-derived outcome measures. RECENT FINDINGS: Noninvasive imaging techniques that assess changes in both atherosclerotic disease burden and plaque composition in response to therapy are well established. With the advent of molecular techniques and hybrid imaging, we now have the ability to assess disease activity alongside these standard anatomic assessments. This multifaceted approach has the potential to provide a more comprehensive assessment of the actions and efficacy of novel therapies in the carotids, aorta and coronary arteries. SUMMARY: This review will examine how advanced noninvasive imaging strategies have been used to investigate drug efficacy in intervention trials to date, and crucially how these approaches are set to evolve and play a central role in developing the next generation of atherosclerotic medication.
Authors: X Q Zhao; C Yuan; T S Hatsukami; E H Frechette; X J Kang; K R Maravilla; B G Brown Journal: Arterioscler Thromb Vasc Biol Date: 2001-10 Impact factor: 8.311
Authors: R Corti; Z A Fayad; V Fuster; S G Worthley; G Helft; J Chesebro; M Mercuri; J J Badimon Journal: Circulation Date: 2001-07-17 Impact factor: 29.690
Authors: P Raggi; T Q Callister; B Cooil; Z X He; N J Lippolis; D J Russo; A Zelinger; J J Mahmarian Journal: Circulation Date: 2000-02-29 Impact factor: 29.690
Authors: M J Budoff; K L Lane; H Bakhsheshi; S Mao; B O Grassmann; B C Friedman; B H Brundage Journal: Am J Cardiol Date: 2000-07-01 Impact factor: 2.778
Authors: Stephan Achenbach; Dieter Ropers; Karsten Pohle; Alexander Leber; Christian Thilo; Andreas Knez; Theresa Menendez; Ralph Maeffert; Magda Kusus; Matthias Regenfus; Andrea Bickel; Ralph Haberl; Gerhard Steinbeck; Werner Moshage; Werner G Daniel Journal: Circulation Date: 2002-08-27 Impact factor: 29.690
Authors: J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg Journal: Circulation Date: 2002-06-11 Impact factor: 29.690
Authors: Gerald F Watts; Samuel S Gidding; Pedro Mata; Jing Pang; David R Sullivan; Shizuya Yamashita; Frederick J Raal; Raul D Santos; Kausik K Ray Journal: Nat Rev Cardiol Date: 2020-01-23 Impact factor: 32.419
Authors: Jennifer G Robinson; Kevin Jon Williams; Samuel Gidding; Jan Borén; Ira Tabas; Edward A Fisher; Chris Packard; Michael Pencina; Zahi A Fayad; Venkatesh Mani; Kerry Anne Rye; Børge G Nordestgaard; Anne Tybjærg-Hansen; Pamela S Douglas; Stephen J Nicholls; Neha Pagidipati; Allan Sniderman Journal: J Am Heart Assoc Date: 2018-10-16 Impact factor: 5.501
Authors: Philip M Robson; Damini Dey; David E Newby; Daniel Berman; Debiao Li; Zahi A Fayad; Marc R Dweck Journal: JACC Cardiovasc Imaging Date: 2017-10